Torrent Pharma

{
  "main_header": {
    "sid": 317368,
    "name": "Torrent Pharma",
    "stock_name": "Torrent Pharma",
    "full_name": "Torrent Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/torrent-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,122.80",
    "chg": 250.7,
    "chgp": "5.15%",
    "dir": 1,
    "prev_price": "4,872.10",
    "mcapval": "187,540.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500420,
    "symbol": "TORNTPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE685A01028",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "21:06 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "18.99 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/torrent-pharma-317368-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Torrent Pharmaceuticals Ltd. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-torrent-pharmaceuticals-ltd-latest-results-good-or-bad-4130631",
        "imagepath": "",
        "date": "2026-07-31 19:19:44",
        "description": "Torrent Pharmaceuticals Ltd. has reported its financial results for Q1 FY27, showcasing a significant growth in net sales but a more modest increase in net profit. The company achieved net sales of ₹4,921 crores, reflecting a year-on-year growth of 54.85% and a sequential increase of 17.25%. This growth appears to be largely driven by recent acquisitions, which have contributed to the highest quarterly revenue in the company's history.\n\nIn contrast, net profit for the same quarter was ₹566 crores, representing only a 3.28% increase year-on-year, although it showed a substantial sequential growth of 55.49% from the previous quarter. The disparity between revenue and profit growth can be attributed to a significant rise in interest expenses and depreciation charges, which surged dramatically due to the company's recent acquisition activities. Interest expenses rose to ₹305 crores from ₹56 crores a year ago, w..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Torrent Pharmaceuticals Ltd. to 52-Week High of Rs 5139.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/torrent-pharmaceuticals-ltd-hits-new-52-week-high-at-rs51393-4130369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TorrentPharmace_priceRelatedfactors_4130369.png",
        "date": "2026-07-31 12:10:21",
        "description": "With a decisive surge to Rs 5139.3 on 31 Jul 2026, Torrent Pharmaceuticals Ltd. has reached a fresh 52-week high, marking a 36.13% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades modestly higher, underscoring the stock’s outperformance within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Torrent Pharmaceuticals Ltd. Hits All-Time High of Rs 5,115 as Momentum Accelerates",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/torrent-pharmaceuticals-ltd-stock-hits-all-time-high-on-31-july-2026-4130338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TorrentPharmace_priceRelatedfactors_4130338.png",
        "date": "2026-07-31 11:51:57",
        "description": "Extending its winning streak after a brief pause, Torrent Pharmaceuticals Ltd. surged 5.02% on 31 Jul 2026 to close at a fresh all-time high of Rs 5,115, outpacing the Sensex which inched up just 0.12% on the day."
      },
      {
        "title": "Torrent Pharmaceuticals Ltd. Rallies 3.55% and Approaches 52-Week High Amid Strong Technical Setup",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/torrent-pharmaceuticals-ltd-hits-intraday-high-with-strong-355-surge-4130307",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TorrentPharmace_priceRelatedfactors_4130307.png",
        "date": "2026-07-31 11:21:22",
        "description": "The Sensex edged up 0.1% on 31 Jul 2026, but Torrent Pharmaceuticals Ltd. outperformed decisively with a 3.55% gain, touching an intraday high of Rs 5,047.20. This 2.8 percentage-point outperformance over its sector signals a stock-specific strength rather than a broad market lift."
      },
      {
        "title": "4,901 Call Contracts Traded on Torrent Pharmaceuticals Ltd. as Stock Nears Rs 5,000 Strike",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/torrent-pharmaceuticals-sees-surge-in-call-option-activity-ahead-of-august-expiry-4129906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TorrentPharmace_most_active_stocks_calls_4129906.png",
        "date": "2026-07-31 10:00:06",
        "description": "On 31 Jul 2026, 4,901 call contracts on Torrent Pharmaceuticals Ltd. changed hands at the Rs 5,000 strike, with the stock closing at Rs 4,932.80. This near-the-money activity coincides with a 1.57% gain in the cash market, signalling a synchronised directional stance between options and underlying price action."
      },
      {
        "title": "Torrent Pharmaceuticals Q1 FY27: Strong Revenue Surge Masks Margin Pressures and Debt Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/torrent-pharmaceuticals-q1-fy27-strong-revenue-surge-masks-margin-pressures-and-debt-concerns-4130292",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TorrentPharmace_quaterlyResult_4130292.png",
        "date": "2026-07-31 09:47:01",
        "description": "Torrent Pharmaceuticals Ltd., one of India's leading pharmaceutical companies specialising in chronic and sub-chronic therapeutic segments, reported a robust revenue performance in Q1 FY27 (Jun'26), with net sales surging 54.85% year-on-year to ₹4,921.00 crores. However, the headline growth conceals mounting operational challenges, as net profit rose a modest 3.28% YoY to ₹566.00 crores, significantly lagging the revenue momentum. The stock has responded positively to the results, trading at ₹5,006.20 with a market capitalisation of ₹1,87,540 crores, reflecting investor optimism despite underlying concerns about profitability and leverage."
      },
      {
        "title": "Torrent Pharmaceuticals Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/torrent-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4115206",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TorrentPharmace_mojoScore_4115206.png",
        "date": "2026-07-22 10:10:03",
        "description": "Torrent Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      },
      {
        "title": "Torrent Pharmaceuticals Ltd. Rallies 3.15% and Approaches 50 DMA Resistance — A Key Technical Test Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/torrent-pharmaceuticals-ltd-hits-intraday-high-with-315-surge-on-20-jul-2026-4109265",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TorrentPharmace_priceRelatedfactors_4109265.png",
        "date": "2026-07-20 12:02:38",
        "description": "Despite a broadly negative market backdrop, Torrent Pharmaceuticals Ltd. surged 3.15% on 20 Jul 2026, outperforming its sector by 2.11 percentage points and the Sensex by nearly 4 percentage points. This strong single-session gain stands out as a stock-specific event amid a 0.75% decline in the benchmark index, signalling a noteworthy shift in the stock’s short-term momentum."
      },
      {
        "title": "Torrent Pharmaceuticals Declines 2.79% Despite New Highs: 5 Key Insights from the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/torrent-pharmaceuticals-declines-279-despite-new-highs-5-key-insights-from-the-week-4107809",
        "imagepath": "",
        "date": "2026-07-19 09:01:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Jul:</strong> New 52-week high at Rs.4,950 and all-time high at Rs.4,951.45</p>\n                    <p><strong>14 Jul:</strong> Further 52-week high at Rs.4,991.55 and all-time high at Rs.4,986.85</p>\n                    <p><strong>15 Jul:</strong> New 52-week and all-time high at Rs.5,041.75, followed by a slight dip</p>\n                    <p><strong>16 Jul:</strong> New 52-week and all-time high at Rs.5,053.05, intraday low at Rs.4,867.10 amid price pressure</p>\n                    <p><strong>17 Jul:</strong> Intraday low at Rs.4,812.85, closing the week with a 4.72% drop on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div ..."
      }
    ],
    "total": 1110,
    "sid": "317368",
    "stock_news_url": "https://www.marketsmojo.com/news/torrent-pharmaceuticals-317368"
  },
  "announcements": [
    {
      "details": "Torrent Pharmaceuticals Limited has informed the Exchange regarding Compliance as per Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
      "source": "NSE",
      "caption": "Torrent Pharmaceuticals Limited - Other General Purpose",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Torrent Pharmaceuticals Limited has informed the Exchange regarding Clarification on Media Reports",
      "source": "NSE",
      "caption": "Torrent Pharmaceuticals Limited - Updates",
      "datetime": "05-Nov-2019"
    },
    {
      "details": "Torrent Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Torrent Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "22-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Torrent Pharmaceuticals Ltd. has declared <strong>180%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Torrent Pharmaceuticals Ltd. has announced <strong>5:10</strong> stock split, ex-date: 20 Feb 06",
          "dt": "2006-02-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Torrent Pharmaceuticals Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 08 Jul 22",
          "dt": "2022-07-08",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Torrent Pharmaceuticals Ltd. latest results good or bad?

2026-07-31 19:19:44

Torrent Pharmaceuticals Ltd. has reported its financial results for Q1 FY27, showcasing a significant growth in net sales but a more modest increase in net profit. The company achieved net sales of ₹4,921 crores, reflecting a year-on-year growth of 54.85% and a sequential increase of 17.25%. This growth appears to be largely driven by recent acquisitions, which have contributed to the highest quarterly revenue in the company's history. In contrast, net profit for the same quarter was ₹566 crores, representing only a 3.28% increase year-on-year, although it showed a substantial sequential growth of 55.49% from the previous quarter. The disparity between revenue and profit growth can be attributed to a significant rise in interest expenses and depreciation charges, which surged dramatically due to the company's recent acquisition activities. Interest expenses rose to ₹305 crores from ₹56 crores a year ago, w...

Read full news article

Broad-Based Technical Strength Lifts Torrent Pharmaceuticals Ltd. to 52-Week High of Rs 5139.3

2026-07-31 12:10:21

With a decisive surge to Rs 5139.3 on 31 Jul 2026, Torrent Pharmaceuticals Ltd. has reached a fresh 52-week high, marking a 36.13% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades modestly higher, underscoring the stock’s outperformance within the Pharmaceuticals & Biotechnology sector.

Read full news article

Torrent Pharmaceuticals Ltd. Hits All-Time High of Rs 5,115 as Momentum Accelerates

2026-07-31 11:51:57

Extending its winning streak after a brief pause, Torrent Pharmaceuticals Ltd. surged 5.02% on 31 Jul 2026 to close at a fresh all-time high of Rs 5,115, outpacing the Sensex which inched up just 0.12% on the day.

Read full news article

Torrent Pharmaceuticals Ltd. Rallies 3.55% and Approaches 52-Week High Amid Strong Technical Setup

2026-07-31 11:21:22

The Sensex edged up 0.1% on 31 Jul 2026, but Torrent Pharmaceuticals Ltd. outperformed decisively with a 3.55% gain, touching an intraday high of Rs 5,047.20. This 2.8 percentage-point outperformance over its sector signals a stock-specific strength rather than a broad market lift.

Read full news article

4,901 Call Contracts Traded on Torrent Pharmaceuticals Ltd. as Stock Nears Rs 5,000 Strike

2026-07-31 10:00:06

On 31 Jul 2026, 4,901 call contracts on Torrent Pharmaceuticals Ltd. changed hands at the Rs 5,000 strike, with the stock closing at Rs 4,932.80. This near-the-money activity coincides with a 1.57% gain in the cash market, signalling a synchronised directional stance between options and underlying price action.

Read full news article

Torrent Pharmaceuticals Q1 FY27: Strong Revenue Surge Masks Margin Pressures and Debt Concerns

2026-07-31 09:47:01

Torrent Pharmaceuticals Ltd., one of India's leading pharmaceutical companies specialising in chronic and sub-chronic therapeutic segments, reported a robust revenue performance in Q1 FY27 (Jun'26), with net sales surging 54.85% year-on-year to ₹4,921.00 crores. However, the headline growth conceals mounting operational challenges, as net profit rose a modest 3.28% YoY to ₹566.00 crores, significantly lagging the revenue momentum. The stock has responded positively to the results, trading at ₹5,006.20 with a market capitalisation of ₹1,87,540 crores, reflecting investor optimism despite underlying concerns about profitability and leverage.

Read full news article

Torrent Pharmaceuticals Ltd. is Rated Hold by MarketsMOJO

2026-07-22 10:10:03

Torrent Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article

Torrent Pharmaceuticals Ltd. Rallies 3.15% and Approaches 50 DMA Resistance — A Key Technical Test Ahead

2026-07-20 12:02:38

Despite a broadly negative market backdrop, Torrent Pharmaceuticals Ltd. surged 3.15% on 20 Jul 2026, outperforming its sector by 2.11 percentage points and the Sensex by nearly 4 percentage points. This strong single-session gain stands out as a stock-specific event amid a 0.75% decline in the benchmark index, signalling a noteworthy shift in the stock’s short-term momentum.

Read full news article

Torrent Pharmaceuticals Declines 2.79% Despite New Highs: 5 Key Insights from the Week

2026-07-19 09:01:03

Key Events This Week

13 Jul: New 52-week high at Rs.4,950 and all-time high at Rs.4,951.45

14 Jul: Further 52-week high at Rs.4,991.55 and all-time high at Rs.4,986.85

15 Jul: New 52-week and all-time high at Rs.5,041.75, followed by a slight dip

16 Jul: New 52-week and all-time high at Rs.5,053.05, intraday low at Rs.4,867.10 amid price pressure

17 Jul: Intraday low at Rs.4,812.85, closing the week with a 4.72% drop on the day

Read full news article

View All News